Novel pharmaceutical compositions and method for treating psychasthenia
AssigneeScience Union et Cie, Societe Francaise de Recherche Medicale
InventorJacques Servier
Life of this patent
Estimating the term…
Abstract
This invention relates to pharmaceutical compositions having psychoanaleptic activity containing a thiamine disulphide derivative as active ingredient. The novel pharmaceutical composition has therapeutical utility, namely, in the treatment of psychic and/or behavioral disturbances due to psychasthenia.
Claims2
A method for treating depressive state in a human subject, and resulting psychic weakness and behavioural disturbance, which consists in administering parenterally, orally, sublingually, or rectally to said subject an amount of bis [(isobutyryloxyethyl) methylene] bis N-[(4-amino 2-methyl 5-pydimidinyl) methyl] formamide disulphide which is effective for said purpose.
Dependencies are inferred from the claim text.